Loading insider details...
Beta
Latest Form 4 (Feb 23, 2026): Grant/Award of 275,000 CNTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 23, 2026 | Context Therapeutics Inc. (CNTX) | Grant/Award | 275,000 | n/a |
| Jun 10, 2025 | Context Therapeutics Inc. (CNTX) | Purchase | 40,010 | $25.5K |
| Feb 14, 2025 | Context Therapeutics Inc. (CNTX) | Grant/Award | 371,800 | n/a |
| Mar 22, 2024 | Context Therapeutics Inc. (CNTX) | Grant/Award | 160,115 | n/a |
| Feb 14, 2023 | Context Therapeutics Inc. (CNTX) | Grant/Award | 158,001 | n/a |
| Dec 19, 2022 | Context Therapeutics Inc. (CNTX) | Purchase | 25,000 | $18.5K |
| Aug 17, 2022 | Context Therapeutics Inc. (CNTX) | Purchase | 15,000 | $27.0K |
| Feb 25, 2022 | Context Therapeutics Inc. (CNTX) | Grant/Award | 112,470 | n/a |
| Nov 1, 2021 | Context Therapeutics Inc. (CNTX) | Grant/Award | 52,753 | n/a |
| Mar 2, 2021 | Millendo Therapeutics, Inc. (MLND) | Grant/Award | 110,000 | n/a |